<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4242750</article-id><article-id pub-id-type="publisher-id">1470-7330-14-S1-P24</article-id><article-id pub-id-type="doi">10.1186/1470-7330-14-S1-P24</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Utility of dual time point 18 FDG PET-CT</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>De Luca</surname><given-names>SE</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>sdeluca@hospitalaleman.com</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Thompson</surname><given-names>JE Codas</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Va&#x000f1;ek</surname><given-names>E Casalini</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Campanelli</surname><given-names>H</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Carrera</surname><given-names>C</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Eyheremendy</surname><given-names>EP</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Hospital Alem&#x000e1;n, Buenos Aires, Argentina</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>9</day><month>10</month><year>2014</year></pub-date><volume>14</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens AG, Healthcare Sector, Imaging and Therapy Division.</named-content></supplement><fpage>P24</fpage><lpage>P24</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 De Luca et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>De Luca et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/14/S1/P24"/><conference><conf-date>9-11 October 2014</conf-date><conf-name>International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</conf-name><conf-loc>Heidelberg, Germany</conf-loc></conference></article-meta></front><body><sec><title/><p>The Standardized Uptake Value (SUV) from FDG PET-CT is a simplified quantitative measure used for characterization of tissues suspected for malignancy. Its rationale is based in augmented glucose consumption of oncologic cells although, many other benign pathologies, could show elevated values leading to error.</p><p>The purpose of this presentation is to demonstrate that SUV value continues elevating in malignant pathology while in benign disease will decrease over time.</p><p>We prospectively acquired delayed images in patients with focal increase of metabolic activity without clear morphologic pathology, or failing to show increase metabolic activity in sites with morphological findings of probable oncologic origin. We have acquired delayed evaluation in 45 patients with suspicious lesions.</p><p>The most prominent findings were: 11 patients with focal hypermetabolic sites in gastrointestinal tract who demonstrate significant SUV decline on delayed images, avoiding unnecessary colonoscopies, while another 17 patients have significantly increased SUV on delayed images, correlated with polypoid lesions at colonoscopy. 7 patients with falling SUV on delayed images in adnexal hypermetabolic foci proved to be of functional origin at ultrasound follow-up, 5 patients with descending SUV at delayed images in hypermetabolic foci in the neck proved to be inflammatory on follow-up and 5 patients that SUV value continues elevating on delayed images, secondary or primary origin was confirmed.</p><p>Dual time point PET-CT has proven to be an important tool for proper characterization of questionable lesions that would lead to costly mistakes or unnecessary diagnostic studies.</p></sec></body></article>